Tags

Type your tag names separated by a space and hit enter

Combination therapy with amphotericin-B and miltefosine for post-kala-azar dermal leishmaniasis: a preliminary report.
Acta Derm Venereol. 2014 Mar; 94(2):242-3.AD

Authors+Show Affiliations

Department of Dermatology, Safdarjung Hospital, 110029 New Delhi, India.No affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Case Reports
Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

23995012

Citation

Ramesh, Venkat, et al. "Combination Therapy With amphotericin-B and Miltefosine for Post-kala-azar Dermal Leishmaniasis: a Preliminary Report." Acta Dermato-venereologica, vol. 94, no. 2, 2014, pp. 242-3.
Ramesh V, Avishek K, Sharma V, et al. Combination therapy with amphotericin-B and miltefosine for post-kala-azar dermal leishmaniasis: a preliminary report. Acta Derm Venereol. 2014;94(2):242-3.
Ramesh, V., Avishek, K., Sharma, V., & Salotra, P. (2014). Combination therapy with amphotericin-B and miltefosine for post-kala-azar dermal leishmaniasis: a preliminary report. Acta Dermato-venereologica, 94(2), 242-3. https://doi.org/10.2340/00015555-1582
Ramesh V, et al. Combination Therapy With amphotericin-B and Miltefosine for Post-kala-azar Dermal Leishmaniasis: a Preliminary Report. Acta Derm Venereol. 2014;94(2):242-3. PubMed PMID: 23995012.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Combination therapy with amphotericin-B and miltefosine for post-kala-azar dermal leishmaniasis: a preliminary report. AU - Ramesh,Venkat, AU - Avishek,Kumar, AU - Sharma,Vanila, AU - Salotra,Poonam, PY - 2013/9/3/entrez PY - 2013/9/3/pubmed PY - 2014/9/12/medline SP - 242 EP - 3 JF - Acta dermato-venereologica JO - Acta Derm Venereol VL - 94 IS - 2 SN - 1651-2057 UR - https://www.unboundmedicine.com/medline/citation/23995012/Combination_therapy_with_amphotericin_B_and_miltefosine_for_post_kala_azar_dermal_leishmaniasis:_a_preliminary_report_ L2 - https://www.medicaljournals.se/acta/content/abstract/10.2340/00015555-1582 DB - PRIME DP - Unbound Medicine ER -